Moberg Pharma AB (publ) (MOBS.XC)

27.22 0.00 (0.00%) At close: 08:34AM BST

Moberg Pharma AB (publ)

Gustavslundsvägen 42
5th Floor
Bromma 167 51
Sweden
46 8 52 23 07 00
https://www.mobergpharma.se

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 9

Description

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.

Corporate governance

Moberg Pharma AB (publ)’s ISS governance QualityScore as of 1 June 2024 is 8. The pillar scores are Audit: 9; Board: 8; Shareholder rights: 4; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.